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Cancer is a major burden of disease
worldwide. Each year, tens of millions of
people are diagnosed with cancer around
theworld,andmorethanhalfofthepatients
eventually die from it. In many countries,
cancer ranks the second most common
causeofdeathfollowingcardiovasculardis-
eases. With significant improvement in
treatment and prevention of cardiovascular
diseases,cancerhasorwillsoonbecomethe
number one killer in many parts of the
world.As elderly people are most suscepti-
ble to cancer and population aging contin-
ues in many countries, cancer will remain a
major health problem around the globe.
In this review, we summarized pub-
lished data to describe the severity of the
burden. We also analyzed the GLOBO-
CAN 2002 database to evaluate the mor-
bidity and mortality of cancer in various
geographic regions around the world. The
GLOBOCAN 2002 database was put to-
gether using the huge amount of data avail-
able in the Descriptive Epidemiology
Group of the International Agency of Re-
search on Cancer (IARC)†, a World Health
Organization agency in Lyon, France [1].
Incidence data are available from cancer
registries.They cover either entire national
populations or samples of such populations
from selected regions. Cancer registries
also provide statistics on cancer survival.
Mortality data by cause are available for
many countries through the registration of
vital events.
Cancer data are always collected and
compiledsometimeaftertheeventstowhich
they relate, so the most recent statistics
available are always “late.” GLOBOCAN
2002 was first made available in September
2005 and presented estimates for 2002.
Theseestimatesarebasedonthemostrecent
incidence,mortality,andsurvivaldataavail-
able at IARC, but more recent figures may
beavailabledirectlyfromlocalsources.The
Age-Standardized Rate (ASR, world stan-
dard) is calculated using the five age groups
of 0 to 14, 15 to 44, 45 to 54, 55 to 64, and
≥ 65 years. The weights of the world stan-
dardpopulationforthefiveagegroupswere
0.31,0.43,0.11,0.08,and0.07,respectively.
OVERALL BURDEN OF
CANCER WORLDWIDE
Based on the GLOBOCAN database,
there were about 10,862,496 new cancer
cases (excluding skin cancer) in the world
in 2002. Of these, 5,801,839 (53.4 percent)
were male and 5,060,657 (46.6 percent)
*To whom all correspondence should be addressed: Herbert Yu, MD, PhD, Associate Pro-
fessor, Department of Epidemiology and Public Health, Yale Cancer Center, Yale University
School of Medicine, 60 College Street, Room 700, New Haven, CT 06520-8034; Tel: 203-
785-5688; Fax: 203-785-6980; E-mail: herbert.yu@yale.edu.
†Abbreviations: IARC, International Agency of Research on Cancer.were female. Nearly 45 percent of the new
cases were diagnosed inAsia, 26 percent in
Europe, 15 percent in NorthAmerica, 7 per-
cent in Latin America, and 6 percent in
Africa. For males and females combined,
the most common cancer site worldwide
was lung (965,446 male and 386,875 female
cases per year). The second most common
site was colon (550,513 males and 472,743
females), followed by stomach (603,003
males and 330,290 females). Among
women, the number one cancer site was
breast (1,152,161 new cases per year), fol-
lowed by cervix (493,100 cases), and colon
(472,743 cases).Among men, the three most
common cancer sites were lung (965,446
cases), prostate (679,060 cases), and stom-
ach (603,003 cases).
The number of deaths caused by cancer
worldwide in 2002 was 6,723,887, among
which 3,795,991 were male and 2,927,896
were female. Lung cancer led to most cancer
deaths in the world. In 2002, the total death
toll due to lung cancer was 1,179,074, of
which 848,321 were male and 330,753 were
female. The second on the list was stomach
cancer, which resulted in a total of 699,803
deaths, including 445,691 in males and
254,112 in females. Liver cancer was the
number three cause of cancer mortality. A
total of 598,412 deaths (416,926 male and
81,486 female) were attributed to liver can-
cer in 2002. For women, the top three sites
for cancer mortality were breast (411,093
deaths), lung (330,753 deaths), and cervix
uteri (273,449 deaths), while lung (848,321),
stomach (445,691), and liver (416,926) con-
stituted the top three sites for cancer mortal-
ity in men.
INCIDENCE OF CANCER
BY GEOGRAPHIC REGIONS
Of the 21 regions listed in the GLOBO-
CAN 2002 database, East Asia had the
largest number of incident cancer cases (all
ages, all sites except skin) in 2002 (n =
2,890,311); North America and South Cen-
tral Asia were second (n = 1,570,520) and
third (n = 1,261,527) on the list, respectively
(Figure 1).The pattern of cancer sites varied
substantially from region to region. For ex-
ample, the three most common cancer sites
among individuals 15 years or older in East
Asia were stomach (18.9 percent), lung
(17.1 percent), and liver (14.3 percent),
whereas those in North America were
prostate (16.5 percent), breast (14.7 per-
cent), and lung (14.5 percent) (Figures 2-3).
For both males and females, the inci-
dence rate of cancer increased substantially
with age. For example, the annual male can-
cer incidence in the age group of 0 to 14
years was 6.45 per 100,000 in Western
Africa, 9.07 per 100,000 in Eastern Asia,
14.10 per 100,000 in Western Europe, and
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Figure 1. Number of Incident Cancer Cases in 2002 (all ages, all sites but skin*).
*No bars are shown for Melanesia, Micronesia, and Polynesia because the numbers of incidence
cancer cases in these three regions were very small.15.12 per 100,000 in North America; the
rates in the same regions for those who were
65 years or older were 385.44, 1461.59,
2327.87 and 2958.14 per 100,000, respec-
tively (Table 1). North America,
Australia/New Zealand, and Europe had the
highest overall incidence rates in 2002,
while Northern and Western Africa had the
lowest incidence rates (Tables 1-2). The ge-
ographic variation was rather substantial.
For example, the age-standardized rate in
North American males (398.4 per 100,000
person-years) was four times of the age-
standardized rate in NorthAfrican males (99
per 100,000 person-years).
The geographic disparity in cancer in-
cidence is largely attributable to the various
socioeconomic, environmental, and lifestyle
factors in different regions of the world.
Compared with developed countries, devel-
oping countries in general may lack the re-
sources to ascertain incident cancer cases.
For example, in developed countries, many
cases of breast, prostate, colon, and cervical
cancers are identified through screening
(e.g. mammography, prostate-specific anti-
gen test, colonoscopy, and Pap smear),
whereas in developing countries, large-scale
screening efforts are usually uncommon.
Genetic factors also play a role, but the dom-
inant effect of genetics is only observed in a
relatively small percentage of the popula-
tion. It is believed that the majority of cancer
cases (over 90 percent) are due to the joint
effect of genetic variations, environmental
factors, and lifestyle choices [2]. Geographic
factor per se probably has little influence on
cancer risk except sunlight exposure and vi-
tamin D metabolism, both of which have
been linked to cancer risk. The major cate-
gories of cancer risk factors include tobacco
use, occupational exposures, environmental
contamination, infectious agents, and
lifestyle factors.
Tobacco use
Knowledge about the role of tobacco
smoking in the etiology of cancer has accu-
mulated for many years [3]. In 2004, the
IARCpublishedamonographontobaccouse
and cancer, which concluded that tobacco
contributed, to a greater or lesser extent, to
cancer in 15 different sites, including lung,
urinarytract,upperrespiratorytract,pancreas,
stomach, and liver.
Although the prevalence of smoking has
declinedinmanydevelopedcountries,itisin-
creasing in developing countries [4]. Cur-
rently, approximately 5 million people are
killed annually by tobacco use; by 2030, esti-
matesbasedoncurrenttrendsindicatethatthis
number will increase to 10 million, with 70
percent of deaths occurring in developing
countries [5]. It is important to adopt policies
such as tobacco tax increases, dissemination
of information about health risks from smok-
ing, restrictions on smoking in public places
and in workplaces, comprehensive bans on
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Figure 2. Type of Incident Cancer in
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Other cancersadvertising and promotion, and increased ac-
cess to cessation therapies to reduce the inci-
dence of cancer and other diseases related to
tobacco use [5].
Occupational exposures
Occupational exposures have long been
linked to the risk of cancer.Arecent publica-
tion listed 28 definitive human occupational
carcinogens ranging from ionizing radiation,
asbestos, silica, wood dust, and arsenic to
benzene [6]. Generally speaking, developed
countries went through the industrialization
process earlier than the developing coun-
tries, and individuals living in developed
countries often had a higher chance of being
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Table 1. Age-specific incidence rate of all cancers (except skin) among males in
2002*.
Table 2. Age-specific incidence rate of all cancers (except skin) among females in
2002*.
*Rates are per 100,000 person-years. **Age-standardized rates using the world standard.
0-14 15-44 45-54 55-64 65+ All ages ASR**
Eastern Africa 16.04 76.94 251.11 443.9 821.06 91 158.7
Middle Africa 10.13 60.1 238.13 443.01 731.93 78.1 141.9
Northern Africa 11.09 27.56 138.95 344.95 583.31 65.8 99
Southern Africa 9.45 52.44 324.88 755.78 1315.28 127.4 213.7
Western Africa 6.49 37.69 193.74 293.41 385.44 51.9 90
Caribbean 12.43 31.28 189.29 532.17 1624.15 177.3 194.4
Central America 14.81 33.86 136.57 386.3 1157.13 100.3 146.1
South America 13.47 40.81 235.81 662.67 1653.23 168.5 216.4
North America 15.12 79.56 424.55 1321.14 2958.14 529.7 398.4
Eastern Asia 9.07 53.53 346.87 663.89 1461.59 227.2 219.4
Southeastern Asia 10.47 30.31 194.44 429.39 833.46 94.3 130.4
South Central Asia 7.24 26.95 166.82 379.62 612.97 76.3 105.5
Western Asia 12.11 33.3 185.69 522.08 989.35 104.4 149.5
Eastern Europe 12.23 50.37 372.94 973.17 1619.75 328.3 257.7
Northern Europe 13.67 51.88 259.85 802.67 2340.02 456.6 283.1
Southern Europe 14.22 61.91 378.34 941.65 2163.41 493.2 299.4
Western Europe 14.1 71.67 402.15 1050.75 2327.87 525.6 326.4
Australia/New Zealand 15.91 77.61 344.04 1024.79 2736.44 483.9 349.7
Melanesia 9.04 36.86 213.33 489.47 912 80.6 145.1
Micronesia 11.04 36.41 170 404.58 1159.27 107.1 151.3
Polynesia 5.47 33.56 266.33 676.44 996.07 116.7 169.3
0-14 15-44 45-54 55-64 65+ All ages ASR*2
Eastern Africa 10.76 82.75 339.77 511.03 564.26 97.7 156.7
Middle Africa 7.55 64.93 274.96 391.14 424.09 76.1 121.5
Northern Africa 8.32 42.25 183.95 271.61 320.83 66.7 85.2
Southern Africa 7.57 69.92 353.05 537.91 698.69 126 163.2
Western Africa 5.25 58.06 272.49 341.17 293.34 66.8 104.4
Caribbean 10.81 68 301.37 448.1 903.83 166.6 164.9
Central America 11.84 54.4 303.63 438.82 824.11 119.7 153.3
South America 11.72 69.57 355.88 562.68 1055.34 176.5 191.6
North American 13.06 116.97 502.96 950.27 1705.66 454.8 305.1
Eastern Asia 5.98 52.56 267.63 399.11 728.11 157.2 136.8
Southeastern Asia 8.44 51.27 284.71 367.38 507 101.4 120.9
South Central Asia 4.64 47.4 265.69 384.08 404.08 88.9 110.1
Western Asia 9.81 48.44 252.93 398.74 602.27 99.3 125.7
Eastern Europe 9.85 76.09 347.65 554.81 809.86 277.2 175.1
Northern Europe 11.18 91.32 438.43 778.15 1414.85 439.1 252.3
Southern Europe 12.48 89.11 398.3 596.42 1062.4 362.5 208.1
Western Europe 11.84 105.2 460.26 731.53 1236.72 429.3 244.6
Australia/New Zealand 13.75 116.05 479.5 851.99 1503.38 405.5 280.3
Melanesia 6.47 70.43 376.98 590.38 628.68 108.1 165
Micronesia 7.61 58.21 304.28 401.98 725.41 110.2 143.8
Polynesia 6.99 92.78 432.81 373.09 568.88 131.3 159.3exposed to various occupational exposures.
However, as many developing countries go
through an economic transition from prima-
rily agricultural activities to more industrial
development and manufacturing, there may
be concerns about the lack of resources in
monitoring occupational exposures and de-
veloping or reinforcing occupational stan-
dards, which is usually an ongoing process.
For example, the current United States’ oc-
cupational standard for benzene, one of the
most widely used industrial chemicals and a
known human carcinogen, is 1 part per mil-
lion (ppm) or 3.26 mg/m3. This is consider-
ably lower than the occupational standard
for benzene in China between 1979 and
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Table 3. Age-specific mortality rates of all cancers (except skin) among males in
2002*.
*Rates are per 100,000 person-years. **Age-standardized rates using the world standard.
Table 4. Age-specific mortality rates of all cancers (except skin) among females in
2002*.
0-14 15-44 45-54 55-64 65+ All ages ASR**
Eastern Africa 10.66 59.17 204.22 380.4 736.85 73.9 133.2
Middle Africa 7.11 49.73 198.74 375.94 646.45 65.6 120.8
Northern Africa 7.28 19.81 111.83 293.42 522.28 53.9 83.1
Southern Africa 6.13 38.82 240.95 584.94 951.5 94.5 158.5
Western Africa 4.14 28.02 152.52 244.21 340.43 41.3 73.5
Caribbean 5.98 16.74 120.01 343.39 1229.53 123.8 135.8
Central America 6.06 14.61 75.72 230.21 859.4 63 95.1
South America 6.35 18.4 131.69 369.27 1112.8 101.1 131.8
North American 2.65 16.3 128.69 417.08 1394.91 210.2 153
Eastern Asia 5.05 31.07 229.81 471.03 1198.95 167 161.8
Southeastern Asia 6.87 19.89 147.18 339.23 692.48 73 102.5
South Central Asia 4.3 15.79 113.69 283.14 495.86 55.2 78
Western Asia 7.27 18.86 122.48 379.68 778.81 74.4 108.7
Eastern Europe 5.53 28.64 256.3 750.41 1356.35 253.5 197.2
Northern Europe 3.33 14.52 131.68 413.01 1517.66 269.9 161
Southern Europe 3.47 20.38 175.51 495.03 1447.52 294.4 170.1
Western Europe 3.09 19.58 177.63 483.88 1518.44 294.6 173.9
Australia/New Zealand 3.7 15.37 110.58 378.27 1412.69 213.9 149.1
Melanesia 5.7 24.69 152.6 358.93 667.37 57.3 104.6
Micronesia 7.97 23.48 128.46 323.52 884.31 80.4 114.5
Polynesia 3.45 20.46 203.46 529.58 738.05 86.1 126.3
0-14 15-44 45-54 55-64 65+ All ages ASR**
Eastern Africa 7.15 60.04 256.42 408.34 482.72 75 122.7
Middle Africa 5.04 52.21 213.85 313.89 375.8 61.5 99
Northern Africa 5.27 29.24 135.05 208.92 276.45 50.2 65.1
Southern Africa 4.67 40.94 219.9 364.99 483.42 81.1 106.3
Western Africa 3.3 41.77 198.17 264.1 253.65 50.2 79.7
Caribbean 5.01 26.66 140.65 269.81 690.16 100.3 98.4
Central America 5.22 20.72 133.72 253.04 630.68 67.9 89.6
South America 5.19 23.87 148.37 285.8 731.22 93.4 102.2
North American 2.32 19.4 124.07 321.35 910.18 185.8 112.1
Eastern Asia 3.74 20.79 134.74 250.45 590.09 100.8 86.3
Southeastern Asia 5.47 24.98 156.44 244.17 385.43 62.5 76.2
South Central Asia 2.79 22.32 151.7 265.77 307.54 55.2 69.9
Western Asia 5.82 21.36 123.79 238.9 432.93 57.7 74
Eastern Europe 4.56 28.97 158.84 326.95 633.93 175.7 101.9
Northern Europe 2.6 20.44 138.34 327.26 958.56 236.9 118.1
Southern Europe 3.04 19.93 119.1 244.68 714.06 189.03 92.2
Western Europe 2.21 20.7 127.62 274.95 864.06 224.9 106.1
Australia/New Zealand 2.67 19.18 116.09 283.8 841.32 167.1 103.4
Melanesia 3.84 37.06 233.53 400.91 424.78 66.5 104.6
Micronesia 4.12 29.33 175.51 261.52 492.51 66.8 88.6
Polynesia 4.81 48.83 268.4 247.04 368.27 79.2 97.62002, which was 40 mg/m3 (area breathing
zone concentration) [7]. In 2002, the occu-
pational standard for benzene in China was
modified and significantly lowered, but the
current standards (10 mg/m3 for short-term
exposure limit and 6 mg/m3 for time-
weighted average) are still higher than the
U.S. standard [7]. Given that hematological
toxicity is observed in workers with benzene
exposures below the level of 1 ppm [8], the
current occupational standards for benzene
may still need to be reviewed and evaluated.
Environmental contamination
Exposure to environmental contamina-
tion, such as indoor air pollution and pesti-
cides, is known to increase the risk of
cancer. More than half of the world’s popu-
lations rely on dung, wood, crop waste, or
coal to meet their most basic energy needs
[9]. Cooking and heating with such solid
fuels on open fires or stoves without chim-
neys lead to indoor air pollution.This indoor
smoke contains a range of health-damaging
pollutants, including small soot or dust par-
ticles, that are able to penetrate the lungs, in-
creasing the risk of lung cancer and other
diseases of the respiratory tract. In poorly
ventilated dwellings, indoor smoke can ex-
ceed acceptable levels for small particles in
outdoor air 100-fold. Exposure is particu-
larly high among women and children, who
spend the most time near the domestic
hearth.The use of polluting fuels thus poses
a major burden on the health of poor fami-
lies in developing countries [9]. As for pes-
ticides, the global market value is estimated
at $32 billion in 2000, with the share of de-
veloping countries around $3 billion [10].
Around 30 percent of pesticides marketed in
developing countries do not meet interna-
tionally accepted quality standards, and the
problem is particularly widespread in sub-
Saharan Africa. These poor-quality pesti-
cides frequently contain hazardous
substances and impurities that already have
been banned or severely restricted elsewhere
and, therefore, pose a serious threat to
human health and the environment [10].
Infectious agents
In 2002, an estimated total of 1.9 mil-
lion cancer cases, or 17.8 percent of the
global cancer burden, were attributed to var-
ious infections [11]. Several infectious
agents are considered to be causes of cancer
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Figure 4. Male age-specific incidence and mortality in more or less developed coun-
tries, 2002. (All sites but skin: male, 2002)[11]. For example, Helicobacter pylori in-
fection is known to increase the risk of stom-
ach cancer [12], whereas infection with
hepatitis B and C viruses can lead to liver
cancer [13]. The relationship between so-
cioeconomic status and the acquisition of
Helicobacter pylori infection has been con-
firmed in a number of studies; the preva-
lence of infection varies from 8.9 percent to
72.8 percent among children from devel-
oped and developing countries, respectively;
the re-infection rate is also significantly
higher in the latter [14]. Similarly, the preva-
lence of infection with hepatitis B and C
viruses is higher in developing countries
than in developed countries [15].The higher
incidences of stomach and liver cancers in
developing countries are largely due to the
higher prevalence of related infections.
Other infections considered to be important
in cancer include human papilloma virus,
Epstein-Barr virus, and human immunode-
ficiency virus [11].
Diet and physical activity
Excessive weight and obesity, resulting
from excess calorie intake and physical inac-
tivity, have become a serious health issue in
many developed countries. In the United
States, for example, it is estimated that
nearly a third of the adult population is
obese and two-thirds are overweight [16].
Obesity and excessive weight have been
linked to many types of cancers, including
those of the colon, breast, and prostate [17].
The higher incidences of colon, breast, and
prostate cancers in developed countries are
attributed in part to a lifestyle of high-calorie
diet and physical inactivity.This lifestyle re-
sults in positive energy imbalance that fur-
ther leads to insulin resistance (or metabolic
syndrome) characterized by hyperinsuline-
mia, dyslipidemia, hypertension, and glu-
cose intolerance [18]. Insulin resistance has
been linked to a number of health problems
including cancer, type 2 diabetes, and car-
diovascular diseases [19].These lifestyle-re-
lated health issues have begun to spread to
certain developing countries where there has
been steady economic growth. This spread
also results in changes in regional cancer
patterns. For example, dramatic increases in
the incidences of breast, prostate, and colon
cancers have been observed in the major
cities of China [20].
MORTALITY OF CANCER
BY GEOGRAPHIC REGIONS
In 2002,Asia had the largest number of
cancer deaths in the world, a total of
3,355,928 deaths, including 1,983,473 males
and 1,372,455 females, followed by Europe
(1,701,472), and North America (631,971).
The mortality of cancer also increased dra-
matically with age for both males and fe-
males (Table 3-4). For males, the highest
age-standardized mortality rate was ob-
served in Eastern Europe (197.2 per 100,000
person-years) and the lowest in Western
Africa (73.5 per 100,000 person-years).The
geographic variation in cancer mortality was
not as substantial as the geographic variation
in cancer incidence. More developed regions
such as North America had relatively low
cancer mortality despite having high cancer
incidence. On the other hand, some less de-
veloped regions had relatively high cancer
mortality despite having low cancer inci-
dence.This disparity is clearly shown in Fig-
ure 4 — the gap between incidence and
mortality in males was larger in more devel-
oped countries than in less developed coun-
tries. There was a similar pattern in females
(data not shown).The disparity could be due
to the different profiles of cancer in more or
less developed countries. For example,
prostate cancer is common in more devel-
oped countries, and it is usually associated
with a fairly good prognosis and does not
have a severe impact on survival. The dis-
parity also could be due to the resources
available for the screening and treatment of
cancer in more or less developed countries.
For example, the incidence rates of female
breast cancer were nearly three-fold higher
in more-developed than less-developed
countries; whereas, mortality rates were less
than two-fold higher in more-developed
than less-developed countries. Conse-
quently, the mortality/incidence rate ratio
varied widely, from a low of 0.19 in North
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Figure 5. Population Pyramid for More (left) or Less (right) Developed Countries, 2002.America to a high of 0.69 inAfrica [21].The
prognosis of certain types of malignancies,
such as cervical cancer and colon cancer,
can be remarkably improved by identifying
cases early through effective screening. Less
developed countries may lack resources to
carry out large scale screenings. It is also
possible that various completeness in cancer
surveillance and vital records in more or less
developed countries contributed to the ap-
parent disparity.
LOOKING INTO THE FUTURE
Cancer is primarily a disease of old age.
If all other factors remain the same, the de-
mographic change (population growth and
an increasingly higher percentage of older
individuals in the world population) will
lead to a global increase of cancer incidence.
The GLOBOCAN 2002 database provides a
means to project cancer incidence in the fu-
ture. In 2002, there were an estimated total
of 5,801,839 male individuals diagnosed
with cancer (all sites except skin). If the age-
specific incidence rates remain the same,
population growth and aging of the world
population would result in a projected total
of 6,993,778 in 2010, a 20.5 percent increase
within eight years (Table 4). The picture is
similar for females. The total number of fe-
males diagnosed with cancer (all sites except
skin) is projected to change from 5,060,657
in 2002 to 6,037,753 in 2010, which repre-
sents a 19.3 percent increase (detailed data
not shown). This underscores the impor-
tance to improve our understanding of the
risk factors of cancer, design and implement
practical prevention strategies, and develop
better and more effective treatment options.
The population compositions are dra-
matically different between more and less
developed countries. Less developed coun-
tries have a smaller percentage of older indi-
viduals (Figure 5). As cancer incidence
increases with age, less developed countries
have a larger population base and potentially
more room for population aging. The fore-
seeable increase in the global burden of can-
cer likely will be more profound in less
developed countries. In a recently published
report, Cancer Control Opportunities in the
Developing World [22], by the Institute of
Medicine of the National Academy of Sci-
ences, it is recognized that cancer is a sig-
nificant disease burden in low- and
middle-income countries, and the burden
will become increasingly heavy for these
countries not only because these nations are
more populous, which give rise to more
cases, but there are also more aggressive
cancers and lower cure rates.The report also
indicates that cancer causes and outcomes
are very different between more and less de-
veloped countries. For example, one in four
cancer cases in developing countries are re-
lated to infectious agents compared to less
than one in 10 cases in the developed na-
tions. These disparities suggest different
cancer prevention and control strategies for
more and less developed countries in direct-
ing resources into the field of cancer re-
search with regard to etiology, prevention,
treatment, and health policy to reduce the
burden of cancer globally.
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